CDR ANTIBODY REACTION APPARATUS
20230204566 · 2023-06-29
Inventors
- Sung Hyun Kang (Daejeon, KR)
- Jong Taek Park (Daejeon, KR)
- You Rim Cha (Daejeon, KR)
- Woo Jong Ha (Sejong-si, KR)
- Heung Seon Shin (Sejong-si, KR)
Cpc classification
International classification
Abstract
A cyclic draining and replenishing (CDR) antibody reaction apparatus according to the present invention comprises: a chamber part inside which an antibody solution is accommodated, and in which a blotting membrane that reacts with the antibody solution is arranged; and a spreader arranged on the blotting membrane in the chamber part, wherein the position of the spreader moves along the top of the blotting membrane.
Claims
1. A CDR antibody reaction apparatus comprising: a chamber part in which an antibody solution is received and in which a blotting membrane that reacts with the antibody solution is disposed; and a spreader disposed on the blotting membrane in the chamber part, wherein the position of the spreader moves along the top of the blotting membrane.
2. The CDR antibody reaction apparatus according to claim 1, wherein as the position of the spreader moves, the antibody solution is evenly spread on the blotting membrane.
3. The CDR antibody reaction apparatus according to claim 1, wherein the antibody solution is removed from the blotting membrane where the spreader is not located above.
4. The CDR antibody reaction apparatus according to claim 1, wherein the chamber part further comprises a partition that partitions the inner space off.
5. The CDR antibody reaction apparatus according to claim 1, wherein the chamber part is provided with a plurality of protrusions formed on both sides of the inner bottom surface, and the plurality of protrusions restrict the movements of the spreader and the mounted membrane by a predetermined distance.
6. The CDR antibody reaction apparatus according to claim 1, wherein the chamber part further comprises a pair of locking projections provided at the front and rear of at least one side and including a receiving groove in which the end of the spreader is received, and wherein the spreader is movable back and forth in the space between the receiving grooves.
7. The CDR antibody reaction apparatus according to claim 1, wherein the spreader is located on the top of the blotting membrane without directly contacting therewith.
8. The CDR antibody reaction apparatus according to claim 1, wherein the top of the chamber part is provided with discharge grooves having a narrower width toward the front.
9. The CDR antibody reaction apparatus according to claim 1, wherein there are one or more spreaders.
Description
DESCRIPTION OF DRAWINGS
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
MODE FOR INVENTION
[0032] Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings. First, it should be noted that in adding reference numerals to the components of each drawing, the same components have the same reference numerals as much as possible even though they are shown in different drawings. Moreover, if it is determined that the subject matter of the present invention may be obscured, a detailed description thereof will be omitted. Furthermore, although preferred embodiments of the present invention will be described below, the technical idea of the present invention is not limited thereto and may be practiced by those skilled in the art.
[0033] Next, a CDR antibody reaction apparatus according to a preferred embodiment of the present invention will be described with reference to
[0034] Referring to
[0035] The chamber part 100 has a semi-cylindrical shape with a hollow bisected cylinder and an open top, in which an antibody solution can be received. The chamber part 100 may be made of, for example, an acrylic material, but is not limited thereto. The shape of the chamber part 100 may have a semi-cylindrical shape, as well as other shapes such as a hexahedral box with an open top.
[0036] In the case of the conventional cylindrical CDR reaction vessel, for each process, it is necessary that the cylindrical reaction vessel be removed from the rotating device and the lid be opened to add or remove a solution, which complicates the use of the reaction vessel and makes process automation difficult.
[0037] On the contrary, since the chamber part 100 of the present invention has an open top, it is easy to remove or add an antibody solution, which is suitable for process automation.
[0038] Moreover, the chamber part 100 may be provided with a blotting membrane 10 that reacts with the antibody solution. Here, in the blotting membrane 10, an antigen which reacts with the antibody solution can be immobilized, and the immobilized antigen may be disposed to face the open top of the chamber part 100.
[0039] In addition, the chamber part 100 may further comprise a partition 110 that partitions the inner space off.
[0040] In this case, the position of the partition 110 may vary depending on the length of the blotting membrane 10 used, and a plurality of partitions may be provided.
[0041] For example, when the length of the blotting membrane 10 used is short as shown in
[0042] On the contrary, when the length of the blotting membrane 10 is long as shown in
[0043] Referring back to
[0044] Referring to
[0045] Moreover, in order to prevent the spreader 200 from being separated from the chamber part 100 when the chamber part 100 is tilted back and forth, it is preferable that the plurality of protrusions 120 extend upward by a predetermined height.
[0046] Referring to
[0047] As the locking projections 130 are provided in this way, the spreader 200 is movable back and forth in the space between the receiving grooves formed in the pair of locking projections 130, and since the spreader 200 moves in a state where the outside is surrounded by the locking projections 130, it is possible to more reliably prevent the spreader 200 from being separated.
[0048] Meanwhile, the top of the chamber part 100 is provided with discharge grooves 140 having a narrower width toward the front, which make it possible for the solution inside the chamber part 100 to be easily discharged through a vessel C disposed on the bottom.
[0049] Moreover, although not shown in detail, when the spreader 200 directly contacts the blotting membrane 10, it is highly likely to damage the membrane, and thus slightly projecting portions may be formed at both ends, which allow the spreader to be disposed at short intervals from the blotting membrane 10. Therefore, the spreader is located at short intervals on the top of the membrane, and the antibody solution is collected in the gap between the spreader and the membrane and at the periphery of the spreader.
[0050] Next, the operation of the CDR antibody reaction apparatus according to a preferred embodiment of the present invention will be described.
[0051] Referring to
[0052] In this state, when a driving force is transmitted from a driving unit (not shown) connected to the chamber part 100, the chamber part 100 may be tilted back and forth based on a longitudinal axis a as shown by the arrows in
[0053] As the chamber part 100 is tilted back and forth in this way, the spreader 200 disposed on the blotting membrane 10 can move back and forth over the chamber part 100.
[0054] This movement of the spreader 200 allows the antibody solution collected at the bottom and periphery of the spreader 200 to move on the blotting membrane 10. That is, the spreader 200 moves in such a manner that the antibody solution is evenly spread on and removed from the blotting membrane 10, and thus it is possible to increase the antigen-antibody binding efficiency by implementing the CDR antibody reaction principle.
[0055] Referring to
[0056] As a result of comparing the performances of the antibody reactions based on the intensity of the signal according to the amount of the sample when the antigen is GAPDH or Beta Actin, it was found that the intensity of the signal was higher when Western blot was performed using the CDR antibody reaction apparatus of the present invention, indicating a higher performance of the antibody reaction than that of the conventional methods. As such, the present invention has an advantage in that an excellent signal quality can be obtained with high sensitivity compared to the conventional methods.
[0057] Referring to
[0058] That is, antigen detection can occur quickly and effectively, thereby reducing antigen reaction time. The present invention increases the efficiency of the antibody reaction.
[0059] Moreover, the CDR antibody reaction apparatus according to the present invention can control the movement of the antibody solution by means of the spreader 200, which allows blotting even with a small amount of antibody solution (0.25 ml to 1.0 ml in the case of mini-blot), and allows a uniform antibody reaction to occur regardless of the membrane size, the placement direction of membrane, and the position within a membrane.
[0060] Referring to
[0061] Here, the values measured at the dots of each membrane were averaged for each column, and the standard error was calculated.
[0062] The amount of antibody solution used was 2 ml to 0.25 ml, and according to the present invention, it is possible to reduce the amount of antibody used and to obtain uniform results.
[0063] Specifically, (1) the signals at the respective dots should theoretically be the same. In the case of the S-CDR method with the spreader, the signal values were more uniform (compared the standard errors of the analysis values). (2) When using the spreader, uniform signals were obtained up to 0.25 ml; however, in the case of the R-CDR method without the spreader, when using the antibodies in amounts of 0.5 and 0.25 ml, the antibody reaction did not occur well in some areas.
[0064] Referring to
[0065] The purpose of the experiment is to determine whether the spreader can promote the movement of the antibody solution to obtain a uniform antibody-antigen reaction even when the membrane is folded or damaged during the experiment.
[0066] As a result, in the case of R-CDR without the spreader, the reaction did not occur well in some areas or the values were not uniform. However, the present invention produced uniform results.
[0067] Next, CDR antibody reaction apparatuses according to other embodiments of the present invention will be described.
[0068]
[0069] As shown in
[0070] Here, two or more spreaders 200b are provided to allow the antibody solution to be restricted within the space between the spreaders 200b, leading to a more precise movement control.
[0071] In the embodiment of
[0072] As shown in
[0073] Accordingly, the spherical spreader 200b moves by the movement of the chamber 100b.
[0074] As shown in
[0075] As shown in
[0076] As a result, as the chamber 100d moves, the relative position of the spreader 200d also moves.
[0077] As shown in
[0078] As mentioned above, the preferred embodiments of the present invention have been described in detail; however, the technical scope of the present invention is not limited to the above-described embodiments and should be interpreted by the claims. Those skilled in the art should appreciate that many modifications and variations are possible without departing from the scope of the present invention.